• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白乙酰转移酶的MYST家族及其与癌症的密切联系。

The MYST family of histone acetyltransferases and their intimate links to cancer.

作者信息

Avvakumov N, Côté J

机构信息

Laval University Cancer Research Center, Hôtel-Dieu de Québec (CHUQ), 9 McMahon Street, Quebec City, Quebec, Canada.

出版信息

Oncogene. 2007 Aug 13;26(37):5395-407. doi: 10.1038/sj.onc.1210608.

DOI:10.1038/sj.onc.1210608
PMID:17694081
Abstract

The histone acetyltransferases (HATs) of the MYST family are highly conserved in eukaryotes and carry out a significant proportion of all nuclear acetylation. These enzymes function exclusively in multisubunit protein complexes whose composition is also evolutionarily conserved. MYST HATs are involved in a number of key nuclear processes and play critical roles in gene-specific transcription regulation, DNA damage response and repair, as well as DNA replication. This suggests that anomalous activity of these HATs or their associated complexes can easily lead to severe cellular malfunction, resulting in cell death or uncontrolled growth and malignancy. Indeed, the MYST family HATs have been implicated in several forms of human cancer. This review summarizes the current understanding of these enzymes and their normal function, as well as their established and putative links to oncogenesis.

摘要

MYST家族的组蛋白乙酰转移酶(HATs)在真核生物中高度保守,负责大部分的细胞核乙酰化作用。这些酶仅在多亚基蛋白复合物中发挥作用,其组成在进化上也具有保守性。MYST HATs参与许多关键的核过程,在基因特异性转录调控、DNA损伤应答与修复以及DNA复制中发挥关键作用。这表明这些HATs或其相关复合物的异常活性很容易导致严重的细胞功能障碍,从而导致细胞死亡或不受控制的生长及恶性肿瘤。事实上,MYST家族HATs已被认为与多种人类癌症有关。本综述总结了目前对这些酶及其正常功能的理解,以及它们与肿瘤发生已确定和推测的联系。

相似文献

1
The MYST family of histone acetyltransferases and their intimate links to cancer.组蛋白乙酰转移酶的MYST家族及其与癌症的密切联系。
Oncogene. 2007 Aug 13;26(37):5395-407. doi: 10.1038/sj.onc.1210608.
2
MYST opportunities for growth control: yeast genes illuminate human cancer gene functions.MYST家族在生长调控方面的机遇:酵母基因揭示人类癌症基因功能
Oncogene. 2007 Aug 13;26(37):5373-84. doi: 10.1038/sj.onc.1210606.
3
Functions of myst family histone acetyltransferases and their link to disease.神秘家族组蛋白乙酰转移酶的功能及其与疾病的关联。
Subcell Biochem. 2007;41:295-317.
4
MYST family histone acetyltransferases take center stage in stem cells and development.MYST家族组蛋白乙酰转移酶在干细胞和发育过程中占据核心地位。
Bioessays. 2009 Oct;31(10):1050-61. doi: 10.1002/bies.200900051.
5
Orchestration of chromatin-based processes: mind the TRRAP.基于染色质的过程的调控:留意TRRAP。
Oncogene. 2007 Aug 13;26(37):5358-72. doi: 10.1038/sj.onc.1210605.
6
HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.组蛋白乙酰转移酶和组蛋白去乙酰化酶:从结构、功能与调控到治疗和预防的新策略
Oncogene. 2007 Aug 13;26(37):5310-8. doi: 10.1038/sj.onc.1210599.
7
Regulation of protein turnover by acetyltransferases and deacetylases.乙酰转移酶和脱乙酰酶对蛋白质周转的调控。
Biochimie. 2008 Feb;90(2):306-12. doi: 10.1016/j.biochi.2007.06.009. Epub 2007 Jul 1.
8
Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.自乙酰化诱导p300组蛋白乙酰转移酶结构域的特定结构变化:通过表面增强拉曼光谱法进行探测
J Phys Chem B. 2007 Oct 18;111(41):11877-9. doi: 10.1021/jp0762931. Epub 2007 Sep 26.
9
Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans.双溴结构域蛋白 BET-1 和 MYST HATs 在秀丽隐杆线虫中建立和维持稳定的细胞命运。
Development. 2010 Apr;137(7):1045-53. doi: 10.1242/dev.042812. Epub 2010 Feb 24.
10
MYST-family histone acetyltransferases: beyond chromatin.MYST 家族组蛋白乙酰转移酶:超越染色质。
Cell Mol Life Sci. 2011 Apr;68(7):1147-56. doi: 10.1007/s00018-010-0599-9. Epub 2010 Dec 4.

引用本文的文献

1
Bromodomain and PHD Finger-Containing Protein 1: From Functions to a Developmental Disorder, Cancer, and Therapeutics.含溴结构域和PHD结构域蛋白1:从功能到发育障碍、癌症及治疗学
Results Probl Cell Differ. 2025;75:411-434. doi: 10.1007/978-3-031-91459-1_15.
2
LOXL2 reduces susceptibility to PARP inhibitors by promoting super-enhancer-regulated DNA damage repair in high-grade serous ovarian cancer.赖氨酰氧化酶样蛋白2(LOXL2)通过促进高级别浆液性卵巢癌中超级增强子调控的DNA损伤修复来降低对聚(ADP-核糖)聚合酶(PARP)抑制剂的敏感性。
Oncogene. 2025 May 31. doi: 10.1038/s41388-025-03466-1.
3
Comprehensive review and outline of genotypes and phenotypes of Arboleda-Tham syndrome spectrum: insights from novel variants.
阿博莱达 - 塔姆综合征谱系的基因型和表型的全面综述与概述:来自新变异的见解
Mol Biol Rep. 2025 Feb 18;52(1):242. doi: 10.1007/s11033-025-10302-y.
4
Modulation of the substrate preference of a MYST acetyltransferase by a scaffold protein.支架蛋白对MYST乙酰转移酶底物偏好性的调控
J Biol Chem. 2025 Mar;301(3):108262. doi: 10.1016/j.jbc.2025.108262. Epub 2025 Feb 3.
5
In silico protein structural analysis of PRMT5 and RUVBL1 mutations arising in human cancers.对人类癌症中出现的PRMT5和RUVBL1突变进行的计算机蛋白质结构分析。
Cancer Genet. 2025 Apr;292-293:49-56. doi: 10.1016/j.cancergen.2025.01.002. Epub 2025 Jan 17.
6
Exploring the various functions of PHD finger protein 20: beyond the unknown.探索PHD指蛋白20的多种功能:超越未知。
Toxicol Res. 2024 Nov 20;41(1):1-11. doi: 10.1007/s43188-024-00265-w. eCollection 2025 Jan.
7
A multivalent engagement of ENL with MOZ.ENL与MOZ的多价结合。
Nat Struct Mol Biol. 2025 Apr;32(4):709-718. doi: 10.1038/s41594-024-01455-8. Epub 2025 Jan 10.
8
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications.组蛋白翻译后修饰在癌症及癌症免疫中的作用:功能、机制及治疗意义
Front Immunol. 2024 Nov 15;15:1495221. doi: 10.3389/fimmu.2024.1495221. eCollection 2024.
9
Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities.癌症表观遗传疗法:最新进展、挑战与新机遇
Epigenomics. 2025 Jan;17(1):59-74. doi: 10.1080/17501911.2024.2430169. Epub 2024 Nov 27.
10
ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B.ERα 状态的浸润性导管乳腺癌是赖氨酸去乙酰化酶 KAT6A 和 KAT6B 之间的调控相互作用的结果。
Sci Rep. 2024 Nov 6;14(1):26935. doi: 10.1038/s41598-024-78432-0.